Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Ettl

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Breast Care (Basel, Switzerland)|May 20, 2021
Luminal Metastatic Breast Cancer: Current Concepts and Future ApproachesJohannes Ettl
Breast Care (Basel, Switzerland)|December 5, 2019
Management of Adverse Events Due to Cyclin-Dependent Kinase 4/6 InhibitorsJohannes Ettl
Breast Care (Basel, Switzerland)|August 6, 2016
Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast CancerJohannes Ettl
Expert Review of Anticancer Therapy|June 27, 2017
The safety and efficacy of palbociclib in the treatment of metastatic breast cancerJohannes Ettl, Nadia Harbeck
Breast Care (Basel, Switzerland)|June 12, 2018
Molecular Tumor BoardsAchim Rody, Johannes Ettl, Frederik Marmé, et al.
Breast Care (Basel, Switzerland)|June 1, 2017
CDK4/6 Inhibitors in the Treatment of Metastatic Breast CancerJohannes Ettl, Jens Huober, Diana Lüftner, et al.
Breast Care (Basel, Switzerland)|February 20, 2018
Highlights from ABC4 - Bridging the GapRachel Wuerstlein, Johannes Ettl, Renate Haidinger, et al.
Cancers|November 13, 2020
Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current LiteratureEirini Thanopoulou, Leila Khader, Morena Caira, et al.
Current Opinion in Obstetrics & Gynecology|December 7, 2018
Translational highlights in breast cancer research and treatment: recent developments with clinical impactPeter A Fasching, Andreas Schneeweiss, Hans-Christian Kolberg, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 29, 2016
Iyengar-Yoga Compared to Exercise as a Therapeutic Intervention during (Neo)adjuvant Therapy in Women with Stage I-III Breast Cancer: Health-Related Quality of Life, Mindfulness, Spirituality, Life Satisfaction, and Cancer-Related FatigueDésirée Lötzke, Florian Wiedemann, Daniela Rodrigues Recchia, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Breast Care (Basel, Switzerland)|May 20, 2021
Luminal Metastatic Breast Cancer: Current Concepts and Future ApproachesJohannes Ettl
Breast Care (Basel, Switzerland)|December 5, 2019
Management of Adverse Events Due to Cyclin-Dependent Kinase 4/6 InhibitorsJohannes Ettl
Breast Care (Basel, Switzerland)|August 6, 2016
Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast CancerJohannes Ettl
Expert Review of Anticancer Therapy|June 27, 2017
The safety and efficacy of palbociclib in the treatment of metastatic breast cancerJohannes Ettl, Nadia Harbeck
Breast Care (Basel, Switzerland)|June 12, 2018
Molecular Tumor BoardsAchim Rody, Johannes Ettl, Frederik Marmé, et al.
Breast Care (Basel, Switzerland)|June 1, 2017
CDK4/6 Inhibitors in the Treatment of Metastatic Breast CancerJohannes Ettl, Jens Huober, Diana Lüftner, et al.
Breast Care (Basel, Switzerland)|February 20, 2018
Highlights from ABC4 - Bridging the GapRachel Wuerstlein, Johannes Ettl, Renate Haidinger, et al.
Cancers|November 13, 2020
Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current LiteratureEirini Thanopoulou, Leila Khader, Morena Caira, et al.
Current Opinion in Obstetrics & Gynecology|December 7, 2018
Translational highlights in breast cancer research and treatment: recent developments with clinical impactPeter A Fasching, Andreas Schneeweiss, Hans-Christian Kolberg, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 29, 2016
Iyengar-Yoga Compared to Exercise as a Therapeutic Intervention during (Neo)adjuvant Therapy in Women with Stage I-III Breast Cancer: Health-Related Quality of Life, Mindfulness, Spirituality, Life Satisfaction, and Cancer-Related FatigueDésirée Lötzke, Florian Wiedemann, Daniela Rodrigues Recchia, et al.
Pageof 10